Brunner, R., Rinner, W., Haberler, C., Kitzberger, R., Sycha, T., Herkner, H., . . . Holzinger, U. (2013). Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: A prospective, randomized, placebo-controlled, double-blinded trial. BioMed Central.

Brunner, Richard, Walter Rinner, Christine Haberler, Reinhard Kitzberger, Thomas Sycha, Harald Herkner, Joanna Warszawska, Christian Madl, et Ulrike Holzinger. Early Treatment With IgM-enriched Intravenous Immunoglobulin Does Not Mitigate Critical Illness Polyneuropathy And/or Myopathy in Patients With Multiple Organ Failure and SIRS/sepsis: A Prospective, Randomized, Placebo-controlled, Double-blinded Trial. BioMed Central, 2013.

Brunner, Richard, et al. Early Treatment With IgM-enriched Intravenous Immunoglobulin Does Not Mitigate Critical Illness Polyneuropathy And/or Myopathy in Patients With Multiple Organ Failure and SIRS/sepsis: A Prospective, Randomized, Placebo-controlled, Double-blinded Trial. BioMed Central, 2013.